D Policy

WELLINGTON, N.Z.—There are prospects for a major change in science and technology policy in New Zealand following the release of a comprehensive and plain-speaking report. The report, completed in December but just now being discussed, said the "key to prosperity" lies in moving the nation rapidly toward a Scandanavian-type economy based on science and technology, (e.g. small, high-value, high tech products in medicine, electronics and biotechnology). The report is named after Sir David Be

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The report is named after Sir David Beattie, a respected former judge and governor-general, whose seven-member committee was asked last year by Bob Tizard, the Minister for Science and Technology, to provide a national blueprint for R&D. The issue is an urgent one because New Zealand is seeking a successful financial niche following a drastic drop in its traditional export income from farm produce.

The committee is pressing for: a doubling in per capita R&D expenditure over the next seven years, from a current base of $250 million; much higher visibility for science, with a more powerful senior minister for science and technology, a cabinet committee, an external advisory board, and three research councils to disburse funds on a competitive basis; a 150 percent tax deductibility to encourage in-house R&D by industry (specifically, to catch up with a similar recent Australian scheme); increased support for universities and for basic research; ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Peter Pockley

    This person does not yet have a bio.

Published In

Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
Explore polypharmacology’s beneficial role in target-based drug discovery

Embracing Polypharmacology for Multipurpose Drug Targeting

Fortis Life Sciences
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

The Scientist Placeholder Image

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

Stirling Ultracold

Meet the Upright ULT Built for Faster Recovery - Stirling VAULT100™

Stirling Ultracold logo
Chemidoc

ChemiDoc Go Imaging System ​

Bio-Rad
The Scientist Placeholder Image

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb